The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
REBECCA project to be featured at the EHMA 2021 Annual Conference
On Thursday, 16 September 2021, the REBECCA project will be featured at the EHMA 2021 Annual Conference. The conference is organised by the European Health Management Association (EHMA), one of the REBECCA project partners, and is the preeminent European conference on health management. It b…
New EU-funded project REBECCA to improve post-treatment in breast cancer
REBECCA, REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data, is a new project funded under the European Union’s Horizon 2020 research and innovation programme. REBECCA aims to tap into the potential of Real-World Data to support clinical researc…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.